Wolters Kluwer provides free access to mpox resources for front-line clinicians, epidemiologists, and medical researchers
Wolters Kluwer provides free access to mpox resources for front-line clinicians, epidemiologists, and medical researchers
One-stop mpox resource page with UpToDate, Lippincott NursingCenter, and Ovid resources available now
With the World Health Organization declaring mpox to be a global health threat for the second time in three years, Wolters Kluwer Health is once again providing free, online access to evidence-based information about the disease in a dedicated mpox resource center. The updated page includes content and tools from UpToDate®, the clinical decision support (CDS) resource, Lippincott NursingCenter®, the knowledge portal for nurses, and the Ovid® medical research platform. These resources are available to doctors, nurses, frontline healthcare workers, and researchers, as well as to the public.
Stacey Caywood, Chief Executive Officer of Wolters Kluwer Health stated, “As global health organizations respond to the mpox outbreak now affecting thousands in west and central Africa, Wolters Kluwer redoubles our efforts to ensure clinicians and researchers are equipped with the best evidence and knowledge available to care for their patients. Timely access to vital information about the virus is essential for global health efforts.”
Visit the Wolters Kluwer Health mpox resource center which includes links to the following resources:
UpToDate and Lippincott Nursing Center for mpox front line care
For clinicians at the front lines of the outbreak who are seeking the most current, evidence-based clinical decision support, several UpToDate mpox topics are available.
UpToDate has also curated a list of orthopoxvirus guidelines from global and national agencies such as CDC, WHO, and other public health organizations.
Useful resources developed specifically for nurses are available from Lippincott Nursing Center. This includes evidence-based practice articles selected from nursing journals as well as an interactive mpox overview presentation.
Ovid for mpox epidemiologists, researchers, and scientists
Timely research articles on mpox from across the Lippincott journal portfolio have been made available for free access.
To aid scientists, epidemiologists and clinical researchers currently using the Ovid medical research platform, Wolters Kluwer developed two Expert Searches focused on mpox. The advanced searches make it easier to navigate the vast body of research and access the latest and most relevant content.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
Media
André Rebelo
Director, External Communications
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240904884645/en/
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now